VMD News
Viemed Healthcare, Inc.
$9.52
+$0.11(+1.17%)
63
Overall
80
Value
54
Tech
57
Quality
Market Cap
$362.60M
Volume
152.49K
52W Range
$6.05 - $12.61
Target Price
$12.50
VMD news: the latest Viemed Healthcare, Inc. headlines, press releases and market updates, newest first.
Latest VMD News
- Guggenheim Sticks to Its Buy Rating for Revolution Medicines (RVMD)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Analysts’ Top Healthcare Picks: Akari Therapeutics (AKTX), Corcept Therapeutics (CORT)TipRanks Newsroom · Oct 1, 2026
- Bernstein Sticks to Their Hold Rating for Revolution Medicines (RVMD)TipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead AssetNewswire TipRanks · Sep 25, 2026
- Revolution Medicines (RVMD) Gets a Buy from Goldman SachsTipRanks Auto-Generated Intelligence Newsdesk · Sep 24, 2026
- Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)TipRanks Newsroom · Sep 13, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VMD | $9.52 | +1.2% | 152.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |